For more than half a century, the NIO has been the patient care, organizational, methodological, research and training center of Hungarian oncology. The NIO research center is Hungary's internationally recognized oncological research infrastructure. It has 7 dedicated research departments and extensive clinical and translational research is carried out in its clinical departments.
The NIO was awarded the highest level available in the accreditation structure of the Organization of European Cancer Institutes (OECI), the Comprehensive Cancer Center certification in 2008, which was renewed in 2013 and 2018, as the only institute in the Central and Eastern European region. One of the key pillars of accreditation is the research activity carried out in the given institute.
The Institute has a state-of-the-art research infrastructure (large instruments) and research support departments such as the centralized biobank, the SPF animal house or the isotope laboratory.
Clinical, translational, epidemiological and basic research are coordinated with significant grant support, unique infrastructure, patients and multidisciplinary expertise, which have been documented in an increasing number of prestigious multidisciplinary journals as first / last authors.
The main areas of research in the NIO are: the analysis of the genetic diversity of the Hungarian population; discovering new targets for developing new therapies; exploring molecular pathways responsible for treatment resistance; identification of new molecular markers for diagnosis and response to therapy; molecular diagnostic facility to ensure the success of precision medicine; prevention and early detection of hereditary cancers (breast, colon and rectum).
Our priority translational research programs:
NIO maintains the National Cancer Registry. Reconciliation of the databases of The National Healthcare System, the National Statistical Agency and the National Cancer Registry is currently underway.
Hungary has recently joined the WHO's International Agency for Research on Cancer (IARC), with which the OOI Research Center is conducting high-level epidemiological researches.